Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1239588-11-4
1245823-50-0
1286281-32-0
1381861-91-1
13937-08-1
1446282-18-3
887599-64-6 | 3-[(3-Fluorobenzyl)oxy]benzoic acid | AA004B6N | MFCD07398695
887831-90-5 | 3-(N-BOC-N-methylamino)phenylboronic acid | AA004CW6 | MFCD03095104
878668-66-7 | 3-((2-Hydroxyphenyl)amino)-6-methyl-1,2,4-triazin-5(4H)-one | AA004EBB | MFCD07392187
88378-59-0 | Actinopyrone A | AA004FOW | MFCD01694000
880158-11-2 | (3'-Nitro-[1,1'-biphenyl]-4-yl)methanol | AA004GLP | MFCD06803033
873302-30-8 | 6,10-Methano-7H-pyrazino[2,3-h][3]benzazepin-7-one,6,8,9,10-tetrahydro- | AA004HLN
874289-56-2 | 3-Borono-4-fluorobenzohydrazide | AA004IXE | MFCD08436072
862507-33-3 | 2-Isopropoxyisonicotinic acid | AA004JOR | MFCD09054678
87128-27-6 | 4-(Hydroxymethyl)benzamide | AA004KMQ | MFCD11643153
87976-26-9 | Phthalic-3,4,5,6-d4 acid | AA004LJY | MFCD00084172